Jagsonpal Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE048B01035
  • NSEID: JAGSNPHARM
  • BSEID: 507789
INR
207.20
-10.95 (-5.02%)
BSENSE

Dec 05

BSE+NSE Vol: 53.71 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Jagsonpal Pharmaceuticals Ltd stock-summary
stock-summary
Jagsonpal Pharmaceuticals Ltd
Small Cap
Pharmaceuticals & Biotechnology
Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana. The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs. Simultaneously, it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd.
Company Coordinates stock-summary
Company Details
T-210 J, Shahpur Jat New Delhi New Delhi : 110049
stock-summary
Tel: 91-011-46181100/46109900
stock-summary
nandita.singh@jagsonpal.com
Registrar Details
MCS Ltd , F-65, , Okhla Industrial Area, Phase - I, New Delhi
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 13.27 Cr
Number of Shares
6.64 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
08-Jan-2025
6.64
13.27
39818943
2
Stock Split
04-May-2024
2.64
13.22
3000
5
Issued under ESOP Scheme
29-Mar-2024
2.64
13.22
100000
5
Issued under ESOP Scheme
04-Jan-2024
2.63
13.17
50000
5
Issued under ESOP Scheme
04-Dec-2023
2.63
13.14
89794
5
Issued under ESOP Scheme
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 9 FIIs (2.12%)

Promoter with highest holding

Aresko Progressive Private Limited (20.01%)

Highest Public shareholder

Manish Gupta (2.57%)

Individual Investors Holdings

21.13%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
Manish Gupta
Managing Director
1.06 cr
Harsha Raghavan
Chairman & Non Executive Dir.
0
Debasis Bikash Nandy
Independent Director
10.8 lacs
Radhika Dudhat
Independent Director
9.5 lacs
Pallavi Dinodia
Independent Director
10.0 lacs
Prithipal Singh Kochhar
Non Executive Director
0
Abhishek Joshi
Company Sec. & Compli. Officer
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceutical Goods
126.60
100.00%
 
100
Pharmaceutical Goods
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
74 Cr
(Quarterly Results - Sep 2025)
Net Profit:
13 Cr
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 1,384 Cr (Small Cap)

stock-summary
P/E

34.00

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

1.14%

stock-summary
Debt Equity

-0.59

stock-summary
Return on Equity

16.98%

stock-summary
Price to Book

5.78